Home Market News Research Analysts’ Weekly Ratings Changes for Babylon (BBLN)

Research Analysts’ Weekly Ratings Changes for Babylon (BBLN)

by MarketBeat News

A number of research firms have changed their ratings and price targets for Babylon (NYSE: BBLN):

  • 6/7/2022 – Babylon was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “
  • 6/1/2022 – Babylon was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “
  • 5/25/2022 – Babylon was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “
  • 5/19/2022 – Babylon was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “
  • 5/16/2022 – Babylon had its price target lowered by analysts at Canaccord Genuity Group Inc. from $8.00 to $5.00. They now have a “buy” rating on the stock.
  • 5/13/2022 – Babylon had its price target lowered by analysts at Citigroup Inc. from $5.00 to $1.50.
  • 5/11/2022 – Babylon was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “
  • 5/5/2022 – Babylon was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “
  • 4/28/2022 – Babylon is now covered by analysts at Berenberg Bank. They set a “hold” rating and a $5.50 price target on the stock.
  • 4/26/2022 – Babylon was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “
  • 4/25/2022 – Babylon had its price target lowered by analysts at BTIG Research from $15.00 to $10.00.
  • 4/18/2022 – Babylon was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “
  • 4/11/2022 – Babylon was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “

Shares of BBLN stock opened at $1.27 on Thursday. Babylon Holdings Limited has a 12-month low of $0.95 and a 12-month high of $16.00. The business has a 50 day simple moving average of $2.00 and a 200 day simple moving average of $4.43. The company has a debt-to-equity ratio of 3.30, a current ratio of 2.20 and a quick ratio of 2.20.

Babylon (NYSE:BBLN – Get Rating) last announced its quarterly earnings data on Thursday, May 12th. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.01). The firm had revenue of $266.45 million during the quarter, compared to the consensus estimate of $238.49 million. Equities research analysts anticipate that Babylon Holdings Limited will post -1.12 EPS for the current year.

A number of institutional investors have recently bought and sold shares of the business. Wells Fargo & Company MN bought a new stake in shares of Babylon in the fourth quarter valued at about $58,000. Mirabella Financial Services LLP acquired a new stake in shares of Babylon during the fourth quarter worth approximately $63,000. JPMorgan Chase & Co. acquired a new stake in shares of Babylon in the fourth quarter valued at approximately $63,000. Goldman Sachs Group Inc. acquired a new stake in shares of Babylon in the fourth quarter valued at approximately $66,000. Finally, Penserra Capital Management LLC bought a new position in Babylon in the fourth quarter valued at approximately $137,000.

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally.

Further Reading

Want More Great Investing Ideas?

Receive News & Ratings for Babylon Holdings Limited Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Babylon Holdings Limited and related companies with MarketBeat.com’s FREE daily email newsletter.

Source links

Related Articles

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy